Cyttron II

Download Profile PDF
At a Glance
  • Status: Active Consortium
  • Year Launched: 2009
  • Initiating Organization: Government of the Netherlands
  • Initiator Type: Government
  • No disease focus
  • Location: Europe

Abstract

How can molecular alterations affect the healthy state of a human being? It is essential to understand this in order to develop new diagnostics and treatments. Yet answering this question requires an all-embracing picture—from molecules to cells to organs to organisms. Current bioimaging tools can only reveal the important aspects on one single level. In Cyttron II, 14 academic and industrial partners collaborate to overcome this problem. The consortium develops tools and integrates the quantitative data of complementary bioimaging technologies to understand the whole picture. In this way it contributes to new powerful diagnostic tools.

Consortium History

The projects of Cyttron II continue on the successful projects of two predecessor consortia: Cyttron and MIIHD. These parent consortia developed new technologies in the period 2004-2009 that form the basis for the bioimaging tools for diagnosis that will be worked on in Cyttron II. The successful outcomes of the parent consortia are as follows:

  • A multimodal database/visualization platform

  • Novel biomarkers of heart disease for bioimaging 

  • New technologies for multimodal imaging correlative imaging and digital pathology

Over the period 2004-2007, the Cyttron I consortium created the following:

  • Two new bioimaging technology products marketed by Netherlands-based companies within four years

  • Seven new patent applications

  • Five new copyrighted software products

  • Five new industrial partnerships

  • More than 170 scientific publications

Given this record and the increased private involvement in this new consortium, an increased economic output is expected for Cyttron II.

Financing

Cyttron II is funded by the FES 2009 program (50 percent government funding, 25 percent public funding, 25 percent private funding).

Sponsors & Partners

Project Coordinator:
Lydia Meesters
phone: +31 (0)71 527 5666 or 5246

Scientific Director:
Jan Pieter Abrahams
phone: +31 (0)71 527 4213

Mailing address:
Gorlaeus Laboratories
P.O. Box 9502
2300 RA Leiden
The Netherlands

Visiting address:
Einsteinweg 55
2333 CC Leiden


Last Updated: 04/14/2016
The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.
Register your consortium  
All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.